{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T06:16:07Z","timestamp":1673936167286},"reference-count":0,"publisher":"American College of Physicians","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Intern Med"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.7326\/j22-0102","type":"journal-article","created":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T22:00:36Z","timestamp":1672696836000},"page":"JC2","source":"Crossref","is-referenced-by-count":0,"title":["In rheumatic heart disease\u2013associated AF, rivaroxaban increased adverse vascular outcomes vs. VKA at 3 y"],"prefix":"10.7326","volume":"176","author":[{"given":"Ellis W.","family":"Lader","sequence":"first","affiliation":[{"name":"WMCHealth Heart and Vascular Institute, Kingston, New York, United States (E.W.L.)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4285","container-title":["Annals of Internal Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T22:02:23Z","timestamp":1673906543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.acpjournals.org\/doi\/10.7326\/J22-0102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.7326\/J22-0102"],"URL":"https:\/\/doi.org\/10.7326\/j22-0102","relation":{},"ISSN":["0003-4819","1539-3704"],"issn-type":[{"value":"0003-4819","type":"print"},{"value":"1539-3704","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}